Trastuzumab in Esophagogastric Cancer: HER2-Testing and Treatment Reality outside Clinical Studies in Germany

We analysed trends over time in palliative first-line chemotherapy in patients with locally advanced or metastatic esophagogastric cancer. Special focus was on frequency and quality of HER2-testing and trends in drug use in combination with trastuzumab. Earlier published data about patients treated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gastroenterol Res Pract
Main Authors: Merx, Kirsten, Barreto Miranda, Manuel, Kellermann, Lenka, Mahlknecht, Ulrich, Lange, Oliver, Gonnermann, Michael, Hofheinz, Ralf-Dieter
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4749805/
https://ncbi.nlm.nih.gov/pubmed/26941786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/1028505
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados